http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-203447425-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93c2aafeb1bcb1019daee345cc8f141
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a18a3c48a66fda20352050fcbd4e49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a022029faba8be73fbfc4a760fc20eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54e3dc2de097e4519d55e6bdd7bf44a
publicationDate 2014-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-203447425-U
titleOfInvention Vitreous chamber injection fixator
abstract The utility model discloses a vitreous chamber injection fixator comprising a concave surface fixing piece, a hollow metal pipe into which a syringe needle is inserted is arranged on the convex surface of the concave surface fixing piece perpendicularly, and the periphery of the concave surface fixing piece is in a concave arc shape. The curvature radius of the concave surface fixing piece is 10-15mm, the height of the hollow metal pipe is 5mm, the inner diameter of the metal pipe is 0.3-0.4mm, outer sleeves made of elastic silica gel materials tightly wrap the inner surface and the outer surface of the hollow metal pipe and the surface of the concave surface fixing piece, and the different distances between the center of the hollow metal pipe to the limbus corneae are selected by different patients. When the vitreous chamber injection fixator is used and placed, the tunica conjunctiva is pushed, then injection is fixed, the sclera injection point on the lower portion and the tunica conjunctiva injection point on the upper portion are not on the same point after the fixator is pulled out, the tunica conjunctiva which bounces back covers the sclera injection point, the intraocular exposure is reduced, and the endophthalmitis is reduced.
priorityDate 2013-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758

Total number of triples: 15.